Swipe the table sideways for more columns.

TrialConditionsStatusPhaseUpdatedMore infoNCT ID
Gene Therapy for CD19-Positive Hematologic Malignancies (SENTRY-CD19)B-cell acute lymphoblastic leukemia, B-cell chronic lymphocytic leukemia, B-cell neoplasm, Burkitt lymphoma, Chronic Disease, DNA Virus Infections, Disease Attributes, Epstein-Barr virus infection, Hemic and Lymphatic Diseases, Herpesviridae infectious disease, Infections, Leukemia, B-Cell, Lymphoma, B-Cell, Marginal Zone, Neoplasms by Histologic Type, Pathologic Processes, Pathological Conditions, Signs and Symptoms, Tumor Virus Infections, acute biphenotypic leukemia, diffuse large B-cell lymphoma, follicular lymphoma, hematologic disorder, high grade B-cell lymphoma, immune system disorder, immunoproliferative disorder, large B-cell lymphoma, leukemia, lymphatic system disorder, lymphoid leukemia, lymphoma, lymphoproliferative syndrome, mantle cell lymphoma, marginal zone lymphoma, mixed phenotype acute leukemia, neoplasm, non-Hodgkin lymphoma, viral infectious diseaseRecruitingPhase 1 / Phase 22026-08-06NCT06533579

1 results · Page 1 of 1

Swipe the table sideways for more columns.

OrganizationsLinked trials
Vironexis Biotherapeutics Inc.2

11 results · Page 1 of 1

Swipe the table sideways for more columns.

Research sitesCityCountryLinked trials
City of HopeDuarteUnited States238
Colorado Blood Cancer InstituteDenverUnited States178
Mayo Clinic, Clinical Trials Referral OfficeJacksonvilleUnited States1
Mayo Clinic, Clinical Trials Referral OfficeRochesterUnited States1
New York Medical CollegeValhallaUnited States71
Oregon Health & Science UniversityPortlandUnited States261
The Ohio State University Wexner Medical CenterColumbusUnited States102
Tristar BMTNashvilleUnited States5
University of North Carolina at Chapel Hill/ University of North Carolina Medical CenterChapel HillUnited States1
University of Texas MD Anderson Cancer CenterHoustonUnited States192
Valkyrie Clinical TrialsLos AngelesUnited States47